Danaher reported 2025 revenue of $24.57 billion and Q1 2026 revenue of $5.95 billion. The thesis depends on bioprocess recovery, diagnostics demand, operating leverage, acquisitions and cash conversion.
References
Sources used in this report
SEC datasetSEC company tickers exchange datasetRetrieved 2026-05-20 · Issuer identity, ticker, exchange and CIKSEC APISEC submissions APIRetrieved 2026-05-20 · Filing chronology and company identitySEC XBRL APISEC companyfacts APIRetrieved 2026-05-20 · Financial statement cross-checksAnnual report2025 Form 10-K filed 2026-02-242026 · Annual business, risk and financial baselineQuarterly reportQ1 2026 Form 10-Q filed 2026-04-212026 · Latest interim financial baseline or chronologyCurrent reportForm 8-K filed 2026-05-072026 · Recent filing chronologyProxy or proxy-related materialDEFA14A filed 2026-03-252026 · Governance and meeting chronology